Disruptyx Therapeutics Limited is a private limited company that can be found at 11 The Square, University Avenue, Glasgow G12 8QQ. Incorporated on 2022-05-06, this 2-year-old company is run by 1 director.
Director Douglas G., appointed on 06 May 2022.
The company is categorised as "research and experimental development on biotechnology" (SIC: 72110). According to CH data there was a change of name on 2022-05-19 and their previous name was Disruptyve Therapeutics Limited.
The last confirmation statement was filed on 2023-05-05 and the deadline for the following filing is 2024-05-19. Furthermore, the accounts were filed on 31 May 2023 and the next filing is due on 28 February 2025.
| Office Address | 11 The Square |
| Office Address2 | University Avenue |
| Town | Glasgow |
| Post code | G12 8QQ |
| Country of origin | United Kingdom |
| Registration Number | SC731650 |
| Date of Incorporation | Fri, 6th May 2022 |
| Industry | Research and experimental development on biotechnology |
| End of financial Year | 31st May |
| Company age | 2 years old |
| Account next due date | Fri, 28th Feb 2025 (298 days left) |
| Account last made up date | Wed, 31st May 2023 |
| Next confirmation statement due date | Sun, 19th May 2024 (2024-05-19) |
| Last confirmation statement dated | Fri, 5th May 2023 |
Position: Director
Appointed: 06 May 2022
The register of persons with significant control that own or have control over the company is made up of 3 names. As BizStats researched, there is Connor B. The abovementioned PSC has 25-50% voting rights and has 25-50% shares. Another entity in the PSC register is George B. This PSC owns 25-50% shares and has 25-50% voting rights. Moving on, there is Douglas G., who also meets the Companies House conditions to be categorised as a PSC. This PSC owns 25-50% shares and has 25-50% voting rights.
Connor B.
| Notified on | 12 September 2022 |
| Nature of control: |
25-50% voting rights 25-50% shares |
George B.
| Notified on | 12 September 2022 |
| Nature of control: |
25-50% voting rights 25-50% shares |
Douglas G.
| Notified on | 6 May 2022 |
| Nature of control: |
25-50% voting rights 25-50% shares |
| Disruptyve Therapeutics | May 19, 2022 |
| Profit & Loss | |
|---|---|
| Accounts Information Date | 2023-05-31 |
| Balance Sheet | |
| Cash Bank On Hand | 150 |
| Net Assets Liabilities | 150 |
| Other | |
| Number Shares Allotted | 150 |
| Par Value Share | 1 |
| Type | Category | Free download | |
|---|---|---|---|
| AA |
Dormant company accounts reported for the period up to 2023/05/31 filed on: 27th, October 2023 |
accounts | Free Download (2 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy